The effect of high BMI on breast cancer screening frequency.
More frequent breast cancer screening may be necessary for women with high body mass index (BMI), according to a study to be presented at RSNA 2017.
Researchers from Sweden sought to identify risk factors associated with tumors not being detected until they were larger than 2 centimeters and to examine the implications for long-term prognosis.
The researchers examined a population-based screening cohort of 2,358 cases of invasive breast cancer incident between 2001 and 2008; 2,012 patients were followed until 2016. The researchers estimated the multiple adjusted odds ratios for the association between percent density (PD), BMI and other patient characteristics, and the main outcome. Disease progression was defined as the first of locoregional relapse, distant metastasis, or death due to breast cancer.[[{"type":"media","view_mode":"media_crop","fid":"64507","attributes":{"alt":" Fredrik Strand, MD","class":"media-image media-image-right","id":"media_crop_5718862648305","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"8249","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 229px; width: 150px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" Fredrik Strand, MD","typeof":"foaf:Image"}}]]
The results showed with screen-detected cancers, both BMI and PD were associated with having a large tumor at diagnosis but for interval cancers, only BMI was associated with having a large tumor. Percent density was associated with having a small tumor. Nulliparity was only significant among screen-detected cases and large tumors were associated with worse prognosis than smaller tumors.
"Our study suggests that when a clinician presents the pros and cons of breast cancer screening to the patient, having high BMI should be an important 'pro' argument," study co-author Fredrik Strand, MD, a radiologist at the Karolinska University Hospital in Stockholm, said in a release. "In addition, our findings suggest that women with high BMI should consider shorter time intervals between screenings."
Strand’s research will continue as he studies how breast density is associated with delayed detection, however his longer-term vision includes the use of artificial intelligence to triage mammographic screening examinations based on breast cancer risk and potential tumor detectability.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.